Dermatitis clinical trials at University of California Health

1 in progress, 0 open to eligible people

Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Sorry, not currently recruiting here
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
at UCLA

Last updated: May 15, 2026